Back to top
more

Becton, Dickinson and Company (BDX)

(Real Time Quote from BATS)

$234.45 USD

234.45
645,413

-1.89 (-0.80%)

Updated Sep 5, 2024 01:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Based in Franklin Lakes, NJ, Becton, Dickinson and Company (BDX) commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. In fiscal 2019, BD’s revenues increased 8.2% to $17.29 billion. Earlier, BD’s operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. However, the company’s organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional.

PerkinElmer (PKI) Receives EUA from FDA for Latest Assay

by Zacks Equity Research

PerkinElmer's (PKI) latest test receives EUA from the FDA, thereby enabling qualified laboratories to detect and differentiate SARS-CoV-2, influenza A, influenza B and RSV.

BD's (BDX) New Manufacturing Facility to Boost Supply Readiness

by Zacks Equity Research

BD's (BDX) latest manufacturing line is expected to not only boost supply capacity but also provide priority access to needles and syringes to the U.S. government.

BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance

by Zacks Equity Research

BD's (BDX) Rotarex Atherectomy System receives expanded 510 (k) clearance from the FDA that can help in the treatment of in-stent restenosis in the United States.

Hologic (HOLX) Launches Novodiag System for On-Demand Testing

by Zacks Equity Research

Hologic (HOLX) introduces the Novodiag system in Europe for on-demand testing of infectious diseases and antimicrobial resistance.

Tesla, Becton, Dickinson and Co, Computer Programs and Systems, AutoNation and Paycom Software highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Tesla, Becton, Dickinson and Co, Computer Programs and Systems, AutoNation and Paycom Software highlighted as Zacks Bull and Bear of the Day

Brian Bolan headshot

Bear Of The Day: Becton, Dickinson and Co (BDX)

by Brian Bolan

Despite a beating the number in the most recent report, this stock has fallen to the lowest Zacks Rank

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.

Here's Why You Should Add Omnicell (OMCL) to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Omnicell (OMCL) on its strategic acquisitions and partnerships supporting each of the three legs of its strategy.

Debanjana Dey headshot

Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on

by Debanjana Dey

Technology-based healthcare stocks like Henry Schein (HSIC), Veeva Systems (VEEV) and BD (BDX) are expected to continue their rally over the next few months.

BD's (BDX) Latest Diagnostic System to Improve Lab Efficiency

by Zacks Equity Research

BD's (BDX) new system is expected to address labs' needs for high-volume processing and increases in efficiency.

BD (BDX) Veritor At-Home COVID-19 Test Receives EUA From FDA

by Zacks Equity Research

EUA for BD's (BDX) At-Home COVID-19 test is expected to boost home testing to prevent outbreaks and limit the rise in COVID-19 cases from the Delta variant.

Here's Why You Should Retain BD (BDX) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.

Here's Why You Should Add Omnicell (OMCL) to Your Portfolio

by Zacks Equity Research

Omnicell (OMCL) ended the second quarter with better-than-expected results, with the top line registering solid year-over-year growth.

Sheraz Mian headshot

Top Research Reports for Microsoft, JPMorgan & AstraZeneca

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), JPMorgan Chase & Co. (JPM), and AstraZeneca PLC (AZN).

BD's (BDX) New Offering to Boost Labs' Flow Cytometry Abilities

by Zacks Equity Research

BD's (BDX) latest product offering is expected to help improve access to instrumentation for complex scientific research to more laboratories.

BD (BDX) Beats on Q3 Earnings and Revenues, Ups '21 View

by Zacks Equity Research

Each of BD's (BDX) core units witnesses strong revenue growth in the fiscal third quarter, thus driving up the overall top line.

Becton Dickinson (BDX) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Becton Dickinson (BDX) delivered earnings and revenue surprises of 11.38% and 8.04%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

Medical Products' Aug 5 Earnings Roster: BDX, RMD & More

by Trina Mukherjee

Let's see how Medical Product companies' stocks like BDX, RMD, CAH, ABMD and XRAY are poised ahead of their earnings releases.

BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?

by Zacks Equity Research

Continued strength in BD's (BDX) Life Sciences segment is expected to have driven up Q3 sales.

Becton Dickinson (BDX) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Add Teleflex (TFX) to Your Portfolio

by Zacks Equity Research

Strong segmental performance in America and Asia is driving the top line for Teleflex (TFX).

Trina Mukherjee headshot

3 Stocks to Tap the Promising Dental Supplies Industry

by Trina Mukherjee

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Sheraz Mian headshot

Q2 Earnings Scorecard & Analyst Reports for Microsoft, AbbVie & Enbridge

by Sheraz Mian

We have provided a real-time scorecard of the Q2 earnings season, in addition to featuring Microsoft (MSFT), AbbVie (ABBV), Enbridge (ENB) and other stocks.

BD's (BDX) Digital Marketplace Set to Improve User Experience

by Zacks Equity Research

BD's (BDX) latest online marketplace is expected to offer a better user experience to its flow cytometry users.

Trina Mukherjee headshot

Grab these 3 MedTech Stocks That Outperformed S&P 500 YTD

by Trina Mukherjee

Snap up these three top stocks, WST, PAHC and RMD, which continue to show promise amid the pandemic and can turn out to be prudent investment choices.